Affymetrix to Webcast Presentation at the 2013 Leerink Swann Global Healthcare Conference

Affymetrix to Webcast Presentation at the 2013 Leerink Swann Global Healthcare Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (Nasdaq: AFFX  ) today announced that it will webcast the Company’s presentation at the Leerink Swann Global Healthcare Conference in New York City on Thursday, February 14, 2013. The live webcast is scheduled to begin at 3:00 p.m. ET and will feature a corporate overview and update by Tim Barabe, executive vice president and chief financial officer.

A live webcast will be available at http://www.affymetrix.com under the "Investors" link. The archived webcast will be available for 30 days.

About Affymetrix

Affymetrix technology is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes. More than 2,300 systems have been shipped around the world and more than 48,000 peer-reviewed papers have been published using the technology. Affymetrix is headquartered in Santa Clara, California, and has manufacturing facilities in Cleveland, Ohio, and Singapore. eBioscience is headquartered in San Diego, California and has manufacturing facilities in San Diego and Vienna, Austria. Including eBioscience, the Company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe, Asia and Latin America.



Affymetrix, Inc.
Doug Farrell, 408-731-5285
Vice President, Investor Relations

KEYWORDS:   United States  North America  California  New York

INDUSTRY KEYWORDS:

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2237453, ~/Articles/ArticleHandler.aspx, 7/22/2014 10:44:58 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...